-
Evolutionary predictability of genetic versus non genetic resistance to anticancer drugs in melanoma
Study
EGAS00001005314
-
Real-time response profiling through serial plasma analyses during FOLFOX treatment in patients with colorectal cancer
Study
EGAS00001004213
-
Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer
Study
EGAS00001005108
-
Genomic landscape and PD-1 blockade in Natural-killer/T cell lymphoma
Study
EGAS00001003828
-
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Study
EGAS00001001632
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
Molecular profiling of metastatic uveal melanoma
Study
EGAS00001004296
-
Single_cell_analysis_of_cytokine_induced_T_cell_states
Study
EGAS00001003215
-
RNA-seq of Liver Cancer
Study
EGAS00001002879
-
Whole Genome Sequencing of HCC
Study
EGAS00001002888
-
Molecular evolution and clinical trajectories of prostate cancer identifies novel markers for risk stratification
Study
EGAS00001002923
-
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140
Study
EGAS00001004460
-
Genome-wide discovery of somatic coding and regulatory variants in Diffuse Large B-cell Lymphoma
Study
EGAS00001002936
-
Whole-exome sequencing and microRNA profiling predicted relapse risk of stage I lung adenocarcinomas
Study
EGAS00001004461
-
A Single-Cell Atlas of the Multicellular Ecosystem of Primary and Metastatic Hepatocellular Carcinoma
Study
EGAS00001004468
-
COVID19 Host Genetic Initiative
Study
EGAS00001005304
-
Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer
Study
EGAS00001003892
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Sequence data for study: Mobilization of tissue-resident memory CD4+ T lymphocytes from bone marrow and their contribution to a systemic secondary immune reaction
Study
EGAS00001005475
-
Contribution of allelic imbalance to colorectal cancer
Study
EGAS00001002966
-
Interethnic comparability in blood pressure GWAS
Study
EGAS00001002991
-
Familial adult myoclonic epilepsy in Sri Lankan and Indian families
Study
EGAS00001004012
-
Mutations in the RAS/MAPK pathway drive replication repair deficient hypermutated tumors and confer sensitivity to MEK inhibition
Study
EGAS00001005008
-
Using de novo assembly to identify structural variation of complex immune system gene regions
Study
EGAS00001005046
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
Systematic comparative analysis of single-nucleotide variants detection methods from single-cell RNA sequencing data
Study
EGAS00001003883
-
CRISPR transduction of iPS cells
Study
EGAS00001005102
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
A living biobank of breast cancer organoids captures disease heterogeneity
Study
EGAS00001002158
-
Integrative molecular analysis of pediatric Anaplastic large cell lymphoma reveals subtypes with distinct immune suppression signatures.
Study
EGAS00001004189
-
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
Study
EGAS00001004235
-
A microRNA-signature that correlates with cognition and is a target against cognitive decline
Study
EGAS00001005627
-
Single-cell RNA-seq of bronchoalveolar lavage (BAL) fluid of late stage severe COVID-19 patients
Study
EGAS00001005634
-
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
Study
EGAS00001005769
-
Rare occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
Study
EGAS00001005909
-
Gut metagenome associations with extensive digital health data in a volunteer-based EstMB cohort
Study
EGAS00001005900
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma (arrays set)
Study
EGAS00001004314
-
A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases
Study
EGAS00001004454
-
Combined clinical and gene expression score identifies high-risk individuals among follicular lymphoma patients on immunotherapy
Study
EGAS00001002566
-
The evolution of hematopoietic cells under cancer therapy
Study
EGAS00001005234
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Myoepithelial progenitors as founder cells of hyperplastic human breast lesions upon PIK3CA transformation
Study
EGAS00001005933
-
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
Study
EGAS00001005963
-
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Study
EGAS00001005984
-
Gain of function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions
Study
EGAS00001003232
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406
-
SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells
Study
EGAS00001004419
-
Methylome sequencing of cell-free DNA and RRBS of solid tissue
Study
EGAS00001006020
-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD_Full_STDY
Study
EGAS00001003249
-
Custom long non-coding RNA capture enhances detection sensitivity in different human sample types.
Study
EGAS00001005418
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
CCL22 chemokine mutations drive natural killer cell lymphoproliferative disease by biasing GPCR signaling
Study
EGAS00001006009
-
ENCORAFENIB COMBINED WITH BINIMETINIB FOR BRAFV600E-MUTATED RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE PHASE II GMMG-BIRMA TRIAL (Hipo_K08K)
Study
EGAS00001005973
-
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis
Study
EGAS00001005982
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Study
EGAS00001006004
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
HSC_colony_many_years_post_allogeneic_bone_marrow_transplant___Bait_set_2
Study
EGAS00001005534
-
Oncogenic cooperation in a human de novo T-ALL model
Study
EGAS00001006055
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Enhanced cortical neural stem cell identity through SMAD/WNT inhibition in human cerebral organoids facilitates emergence of outer radial glial cells
Study
EGAS00001006063
-
single cell RNA-seq and ATAC-seq of human fetal forebrain tissue
Study
EGAS00001006136
-
A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Study
EGAS00001004704
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
Dissecting features of epigenetic variants underlying cardiometabolic risk using full-resolution epigenome profiling in regulatory elements
Study
EGAS00001003415
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
Genomic analysis of a hypermutated gliosarcoma
Study
EGAS00001004864
-
The effect of pre-analytical and physiological variables on cell-free DNA fragmentation
Study
EGAS00001005748
-
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune-editing in lung cancer
Study
EGAS00001006298
-
Exome sequencing of synchronous colorectal cancers
Study
EGAS00001003474
-
The European MAPPYACTS trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
Study
EGAS00001005935
-
RNA-seq on patient-derived, stage II, CRC cell lines
Study
EGAS00001005948
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs drug target discovery in ankylosing spondylitis
Study
EGAS00001006233
-
Human genome-wide variations in the Massim region
Study
EGAS00001006010
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
Phase 1 CX-5461 Trial (Canadian Cancer Trials Group Trial IND.231)
Study
EGAS00001006173
-
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
Study
EGAS00001006422
-
MutWP5__CRUK_Mutographs_of_Cancer__Cancer_Mastectomy__Exome__Novaseq_
Study
EGAS00001003528
-
Arriba: accurate and efficient detection of gene fusions from RNA-Seq (H021)
Study
EGAS00001003554
-
Widespread hypertranscription in aggressive human cancers
Study
EGAS00001006365
-
Exome & MiSeq sequencing of individuals with Huntington's disease
Study
EGAS00001006383
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Whole Transcriptome Sequencing
Study
EGAS00001006528
-
Resolving the immune landscape of human prostate at a single cell level in health and cancer
Study
EGAS00001005787
-
Massively parallel single-cell B-cell receptor sequencing enables rapid discovery of diverse antigen-reactive antibodies
Study
EGAS00001003663
-
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Study
EGAS00001003672
-
Multimodal Epigenetic Sequencing Analysis (MESA) of Cell-free DNA for Non-invasive Cancer Detection
Study
EGAS00001006462
-
HSC_colony_many_years_post_allogeneic_bone_marrow_transplant___Bait_set_3
Study
EGAS00001006572
-
Whole Genome Sequencing on OCIAML-22
Study
EGAS00001006513
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Exome Sequencing
Study
EGAS00001006529
-
Adult human kidney organoids originate from CD24+ cells and represent an advanced model for adult polycystic kidney disease
Study
EGAS00001006551
-
GENOMIC MUTATION LANDSCAPE OF SKIN CANCERS FROM DNA REPAIR-DEFICIENT XERODERMA PIGMENTOSUM PATIENTS
Study
EGAS00001006732
-
Tocilizumab treatment leads to early resolution of myeloid dysfunction and lymphopenia in patients hospitalized with COVID-19
Study
EGAS00001006688
-
GRIDSS, PURPLE, LINX: Unscrambling the tumor genome via integrated analysis of structural variation and copy number
Study
EGAS00001004034
-
The landscape of chromothripsis across adult cancer types
Study
EGAS00001004250
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
Study
EGAS00001006778
-
Single-cell atlas of multiple myeloma and precursor diseases
Study
EGAS00001006694
-
Malignant progression of an ancestral bone marrow clone harboring a CIC-NUTM2A fusion in isolated myeloid sarcoma
Study
EGAS00001006833